{"id":62282,"date":"2025-12-02T01:03:49","date_gmt":"2025-12-02T00:03:49","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\/"},"modified":"2025-12-02T01:03:49","modified_gmt":"2025-12-02T00:03:49","slug":"alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\/","title":{"rendered":"Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners"},"content":{"rendered":"
\n

VANCOUVER, British Columbia & DALLAS–(BUSINESS WIRE)–Alpha Cognition Inc. (Nasdaq: ACOG) (\u201cAlpha Cognition\u201d or the \u201cCompany\u201d), a commercial-stage biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced that Alpha Cognition will participate in an upcoming virtual fireside chat hosted by Boris Peaker of Titan Partners. The discussion will focus on commercialization efforts and research initiatives to accelerate commercial adoption.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nPresentation Details: Titan Partners Fireside Chat<\/b>\n<\/p>\n

\nDate: <\/b>December 2, 2025
\n
Time: <\/b>12:00 pm \u2013 1:00 pm EST
\n
Participant: <\/b>Michael McFadden, CEO
\n
Host<\/b>:<\/b> Boris Peaker, Managing Director, Titan Partners
\n
Link to Register: <\/b>https:\/\/us06web.zoom.us\/webinar\/register\/WN_5W_rY9BrSZ2eqv3dp_FqoQ<\/a>\n<\/p>\n

\nAbout Alpha Cognition Inc.<\/b>\n<\/p>\n

\nAlpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer\u2019s disease and cognitive Impairment with mild Traumatic Brain Injury (\u201cmTBI\u201d), for which there are currently no approved treatment options.\n<\/p>\n

\nALPHA-1062 formulated as a delayed release oral tablet (ZUNVEYL\u00ae<\/sup><\/b>), is an FDA approved new generation acetylcholinesterase inhibitor for the treatment of Alzheimer\u2019s disease, with expected minimal gastrointestinal side effects. ZUNVEYL\u2019s active metabolite is differentiated from donepezil and rivastigmine in that it binds neuronal nicotinic receptors, most notably the alpha-7 subtype, which is known to have a positive effect on cognition. ALPHA-1062 is also being developed in combination with memantine to treat moderate to severe Alzheimer\u2019s dementia, and as a sublingual formulation for cognitive Impairment with mTBI.\n<\/p>\n

\nForward-looking Statements<\/b>\n<\/p>\n

\nThis news release includes forward-looking statements within the meaning of applicable securities laws. Except for statements of historical fact, any information contained in this news release may be a forward\u2010looking statement that reflects the Company\u2019s current views about future events and are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. In some cases, you can identify forward\u2010looking statements by the words \u201cmay,\u201d \u201cmight,\u201d \u201cwill,\u201d \u201ccould,\u201d \u201cwould,\u201d \u201cshould,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201cobjective,\u201d \u201canticipate,\u201d \u201cbelieve,\u201d \u201cestimate,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201cpotential,\u201d \u201ctarget,\u201d \u201cseek,\u201d \u201ccontemplate,\u201d \u201ccontinue\u201d and \u201congoing,\u201d or the negative of these terms, or other comparable terminology intended to identify statements about the future. Forward\u2010looking statements may include statements regarding the, the long-term benefits of ZUNVEYL, the Company\u2019s timing and planned activities and business strategy to launch ZUNVEYL, the potential timing for the availability of ZUNVEYL, the potential future developments of ZUNVEYL, the market size and demand for ZUNVEYL and the Company\u2019s potential growth opportunities, capital requirements. Although the Company believes to have a reasonable basis for each forward-looking statement, we caution you that these statements are based on a combination of facts and factors currently known by us and our expectations of the future, about which we cannot be certain. The Company cannot assure that the actual results will be consistent with these forward-looking statements. These forward-looking statements are subject to certain risks, including risks regarding our ability to raise sufficient capital to implement our plans to commercialize ZUNVEYL, risks related to our focus on the long-term care market, risks regarding the efficacy and tolerability of ZUNVEYL, risks related to ongoing regulatory oversight on the safety of ZUNVEYL, risk related to market adoption of ZUNVEYL, risks related to the Company\u2019s intellectual property in relation to ZUNVEYL, risks related to the commercial manufacturing, distribution, marketing and sale of ZUNVEYL, risks related to product liability and other risks as described in the Company\u2019s filings with Canadian securities regulatory authorities and available at www.sedar.com<\/a> and the Company\u2019s filings with the United States Securities and Exchange Commission (the \u201cSEC\u201d), including those risk factors under the heading \u201cRisk Factors\u201d in the Company\u2019s Form S-1\/A registration statement as filed with the SEC on January 10, 2025 and available at www.sec.gov<\/a>. These forward\u2010looking statements speak only as of the date of this news release and the Company undertakes no obligation to revise or update any forward\u2010looking statements for any reason, even if new information becomes available in the future, except as required by law.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFor further information:
\n
Investor Relations
\n
IR@alphacognition.com<\/a>
https:\/\/www.alphacognition.com\/<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

VANCOUVER, British Columbia & DALLAS–(BUSINESS WIRE)–Alpha Cognition Inc. (Nasdaq: ACOG) (\u201cAlpha Cognition\u201d or the \u201cCompany\u201d), a commercial-stage biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced that Alpha Cognition will participate in an upcoming virtual fireside chat hosted by Boris Peaker of Titan Partners. The discussion will focus on commercialization efforts and research … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62282","6":"format-standard","7":"category-industry"},"yoast_head":"\nAlpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"VANCOUVER, British Columbia & DALLAS–(BUSINESS WIRE)–Alpha Cognition Inc. (Nasdaq: ACOG) (\u201cAlpha Cognition\u201d or the \u201cCompany\u201d), a commercial-stage biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced that Alpha Cognition will participate in an upcoming virtual fireside chat hosted by Boris Peaker of Titan Partners. The discussion will focus on commercialization efforts and research ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-02T00:03:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251201982685\/en\/2657854\/22\/Alpha_Cognition_Logo_2025_4C.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners\",\"datePublished\":\"2025-12-02T00:03:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\\\/\"},\"wordCount\":712,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251201982685\\\/en\\\/2657854\\\/22\\\/Alpha_Cognition_Logo_2025_4C.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\\\/\",\"name\":\"Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251201982685\\\/en\\\/2657854\\\/22\\\/Alpha_Cognition_Logo_2025_4C.jpg\",\"datePublished\":\"2025-12-02T00:03:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251201982685\\\/en\\\/2657854\\\/22\\\/Alpha_Cognition_Logo_2025_4C.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251201982685\\\/en\\\/2657854\\\/22\\\/Alpha_Cognition_Logo_2025_4C.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\/","og_locale":"en_US","og_type":"article","og_title":"Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners - Pharma Trend","og_description":"VANCOUVER, British Columbia & DALLAS–(BUSINESS WIRE)–Alpha Cognition Inc. (Nasdaq: ACOG) (\u201cAlpha Cognition\u201d or the \u201cCompany\u201d), a commercial-stage biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced that Alpha Cognition will participate in an upcoming virtual fireside chat hosted by Boris Peaker of Titan Partners. The discussion will focus on commercialization efforts and research ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\/","og_site_name":"Pharma Trend","article_published_time":"2025-12-02T00:03:49+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251201982685\/en\/2657854\/22\/Alpha_Cognition_Logo_2025_4C.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners","datePublished":"2025-12-02T00:03:49+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\/"},"wordCount":712,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251201982685\/en\/2657854\/22\/Alpha_Cognition_Logo_2025_4C.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\/","url":"https:\/\/pharma-trend.com\/en\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\/","name":"Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251201982685\/en\/2657854\/22\/Alpha_Cognition_Logo_2025_4C.jpg","datePublished":"2025-12-02T00:03:49+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251201982685\/en\/2657854\/22\/Alpha_Cognition_Logo_2025_4C.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251201982685\/en\/2657854\/22\/Alpha_Cognition_Logo_2025_4C.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/alpha-cognition-to-participate-in-virtual-fireside-chat-hosted-by-titan-partners\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62282","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62282"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62282\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62282"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62282"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62282"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}